Literature DB >> 11682454

PKC- and ERK-dependent activation of I kappa B kinase by lipopolysaccharide in macrophages: enhancement by P2Y receptor-mediated CaMK activation.

B C Chen1, W W Lin.   

Abstract

1. Although accumulating studies have identified I kappa B kinase (IKK) to be essential for controlling NF-kappa B activity in response to several cytokines, the upstream kinases that control IKK activity are still not completely known. We have previously reported that G protein-coupled P2Y(6) receptor activation by UTP potentiates lipopolysaccharide (LPS)-induced I kappa B phosphorylation and degradation, and NF-kappa B activation in J774 macrophages. In this study, we investigated the upstream kinases for IKK activation by UTP and LPS. 2. In murine J774 macrophages, LPS-induced NF-kappa B activation was inhibited by the presence of PDTC, D609, Ro 31-8220, PD 098059 and SB 203580. 3. Accompanying NF-kappa B activation, LPS induced I kappa B degradation and IKK activation were reduced by PDTC, D609, Ro 31-8220 and PD 098059, but not by SB 203580. 4. Although UTP itself slightly induced IKK activation, this response was synergistic with LPS. BAPTA/AM and KN-93 (a calcium/calmodulin-dependent protein kinase (CaMK) inhibitor) attenuated UTP- but not LPS-stimulated IKK activity. Synergistic IKK activation between LPS and thapsigargin was further demonstrated in peritoneal macrophages. 5. LPS and UTP co-stimulation additively increased p65 NF-kappa B phosphorylation. In vitro kinase assays revealed that LPS and UTP induced extracellular signal-regulated protein kinase (ERK) and p38 mitogen-activated protein kinase activation were respectively inhibited by PD098059 and SB 203580. 6. Taken together, we demonstration that Gq protein-coupled P2Y(6) receptor activation can potentiate LPS-stimulated IKK activity. While PKC and ERK participate in IKK activation by LPS and UTP, the phosphatidylinositide-phospholipase C-dependent activation of CaMK plays a major role in UTP potentiation of the LPS response.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11682454      PMCID: PMC1573027          DOI: 10.1038/sj.bjp.0704334

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  53 in total

1.  Rac1 regulates interleukin 1-induced nuclear factor kappaB activation in an inhibitory protein kappaBalpha-independent manner by enhancing the ability of the p65 subunit to transactivate gene expression.

Authors:  C A Jefferies; L A O'Neill
Journal:  J Biol Chem       Date:  2000-02-04       Impact factor: 5.157

2.  Bradykinin stimulates NF-kappaB activation and interleukin 1beta gene expression in cultured human fibroblasts.

Authors:  Z K Pan; B L Zuraw; C C Lung; E R Prossnitz; D D Browning; R D Ye
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

3.  A synthetic inhibitor of the mitogen-activated protein kinase cascade.

Authors:  D T Dudley; L Pang; S J Decker; A J Bridges; A R Saltiel
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

Review 4.  The NF-kappa B and I kappa B proteins: new discoveries and insights.

Authors:  A S Baldwin
Journal:  Annu Rev Immunol       Date:  1996       Impact factor: 28.527

5.  Potentiation of lipopolysaccharide-induced IL-6 release by uridine triphosphate in macrophages: cross-interaction with cyclooxygenase-2-dependent prostaglandin E(2) production.

Authors:  B C Chen; W W Lin
Journal:  J Biomed Sci       Date:  1999 Nov-Dec       Impact factor: 8.410

6.  Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway.

Authors:  Z Chen; J Hagler; V J Palombella; F Melandri; D Scherer; D Ballard; T Maniatis
Journal:  Genes Dev       Date:  1995-07-01       Impact factor: 11.361

7.  Analysis of the role of protein kinase C-alpha, -epsilon, and -zeta in T cell activation.

Authors:  E M Genot; P J Parker; D A Cantrell
Journal:  J Biol Chem       Date:  1995-04-28       Impact factor: 5.157

8.  Activation of the IkappaB alpha kinase complex by MEKK1, a kinase of the JNK pathway.

Authors:  F S Lee; J Hagler; Z J Chen; T Maniatis
Journal:  Cell       Date:  1997-01-24       Impact factor: 41.582

9.  Cholinergic stimulation of AP-1 and NF kappa B transcription factors is differentially sensitive to oxidative stress in SH-SY5Y neuroblastoma: relationship to phosphoinositide hydrolysis.

Authors:  X Li; L Song; R S Jope
Journal:  J Neurosci       Date:  1996-10-01       Impact factor: 6.167

10.  Platelet-activating factor induces NF-kappa B activation through a G protein-coupled pathway.

Authors:  V V Kravchenko; Z Pan; J Han; J M Herbert; R J Ulevitch; R D Ye
Journal:  J Biol Chem       Date:  1995-06-23       Impact factor: 5.157

View more
  41 in total

Review 1.  International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy.

Authors:  Maria P Abbracchio; Geoffrey Burnstock; Jean-Marie Boeynaems; Eric A Barnard; José L Boyer; Charles Kennedy; Gillian E Knight; Marta Fumagalli; Christian Gachet; Kenneth A Jacobson; Gary A Weisman
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

Review 2.  HER-2 and NF-kappaB as the targets for therapy-resistant breast cancer.

Authors:  Kazi M Ahmed; Ning Cao; Jian Jian Li
Journal:  Anticancer Res       Date:  2006 Nov-Dec       Impact factor: 2.480

3.  The curative effect of fucoidan on visceral leishmaniasis is mediated by activation of MAP kinases through specific protein kinase C isoforms.

Authors:  Gunjan Sharma; Susanta Kar; Writoban Basu Ball; Kuntal Ghosh; Pijush K Das
Journal:  Cell Mol Immunol       Date:  2014-02-24       Impact factor: 11.530

4.  Signaling from p53 to NF-kappa B determines the chemotherapy responsiveness of neuroblastoma.

Authors:  Michael B Armstrong; Xin Bian; Yihong Liu; Chitra Subramanian; Anthony B Ratanaproeksa; Feng Shao; Victor C Yu; Roland P S Kwok; Anthony W Opipari; Valerie P Castle
Journal:  Neoplasia       Date:  2006-11       Impact factor: 5.715

5.  Sulfonylurea receptor 1 contributes to the astrocyte swelling and brain edema in acute liver failure.

Authors:  A R Jayakumar; V Valdes; X Y Tong; N Shamaladevi; W Gonzalez; M D Norenberg
Journal:  Transl Stroke Res       Date:  2014-01-18       Impact factor: 6.829

6.  Inter-α-inhibitor Ameliorates Endothelial Inflammation in Sepsis.

Authors:  Vandy P Stober; Yow-Pin Lim; Steven Opal; Lisheng Zhuo; Koji Kimata; Stavros Garantziotis
Journal:  Lung       Date:  2019-04-26       Impact factor: 2.584

7.  Src suppressed C kinase substrate regulates the lipopolysaccharide-induced TNF-alpha biosynthesis in rat astrocytes.

Authors:  Lin-lin Sun; Chun Cheng; Hai-ou Liu; Cong-cong Shen; Feng Xiao; Jing Qin; Jun-ling Yang; Ai-guo Shen
Journal:  J Mol Neurosci       Date:  2007       Impact factor: 3.444

8.  Enhancement of lipopolysaccharide-stimulated JNK activity in rat aortic smooth muscle cells by pharmacological and adenovirus-mediated inhibition of inhibitory kappa B kinase signalling.

Authors:  Christopher J MacKenzie; Andrew Paul; Susan Wilson; Rainer de Martin; Andrew H Baker; Robin Plevin
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

9.  Signaling mechanisms of enhanced neutrophil phagocytosis and chemotaxis by the polysaccharide purified from Ganoderma lucidum.

Authors:  Ming-Jen Hsu; Shiuh-Sheng Lee; Sho Tone Lee; Wan-Wan Lin
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

10.  Mutations on the Switch III region and the alpha3 helix of Galpha16 differentially affect receptor coupling and regulation of downstream effectors.

Authors:  May Ym Yu; Maurice Kc Ho; Andrew Mf Liu; Yung H Wong
Journal:  J Mol Signal       Date:  2008-11-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.